Summary of Use during Lactation

No information is available on the use of ferric pyrophosphate citrate during breastfeeding and the manufacturer recommends that it not be used during breastfeeding. An alternate intravenous drug with more published data available may be preferred. Holder pasteurization of milk reduces the concentration of iron in milk by about 6.5%.[1]

For additional information on iron use during breastfeeding, see the monograph on Iron Salts.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Ferric Carboxymaltose, Ferric Derisomaltose, Iron Sucrose

References

1.

Mohd-Taufek N, Cartwright D, Davies M, et al. The effect of pasteurization on trace elements in donor breast milk. J Perinatol. 2016;36:897–900. [PubMed: 27253894]

Substance Name

Ferric Pyrophosphate Citrate

CAS Registry Number

1332-96-3

Drug Class

Breast Feeding

Lactation

Ferric Compounds

Hematinics

Iron Compounds